Bank of New York Mellon’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-132,343
| Closed | -$13.5M | – | 4418 |
|
|
2023
Q2 | $13.5M | Buy |
132,343
+30,668
| +30% | +$3.13M | ﹤0.01% | 1783 |
|
|
2023
Q1 | $9.24M | Sell |
101,675
-277
| -0.3% | -$25.2K | ﹤0.01% | 1972 |
|
|
2022
Q4 | $3.87M | Buy |
101,952
+2,573
| +3% | +$97.7K | ﹤0.01% | 2487 |
|
|
2022
Q3 | $2.5M | Buy |
99,379
+7,071
| +8% | +$178K | ﹤0.01% | 2697 |
|
|
2022
Q2 | $2.81M | Sell |
92,308
-28,367
| -24% | -$862K | ﹤0.01% | 2642 |
|
|
2022
Q1 | $3.95M | Buy |
120,675
+1,927
| +2% | +$63.1K | ﹤0.01% | 2549 |
|
|
2021
Q4 | $3.13M | Sell |
118,748
-6,420
| -5% | -$169K | ﹤0.01% | 2726 |
|
|
2021
Q3 | $12.6M | Buy |
125,168
+5,999
| +5% | +$604K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $16.9M | Buy |
119,169
+24,079
| +25% | +$3.41M | ﹤0.01% | 1829 |
|
|
2021
Q1 | $9.48M | Sell |
95,090
-1,296
| -1% | -$129K | ﹤0.01% | 2111 |
|
|
2020
Q4 | $11.9M | Buy |
96,386
+2,806
| +3% | +$347K | ﹤0.01% | 1916 |
|
|
2020
Q3 | $9.12M | Sell |
93,580
-4,708
| -5% | -$459K | ﹤0.01% | 1899 |
|
|
2020
Q2 | $15.3M | Sell |
98,288
-20,526
| -17% | -$3.2M | ﹤0.01% | 1605 |
|
|
2020
Q1 | $17.1M | Sell |
118,814
-4,868
| -4% | -$703K | 0.01% | 1388 |
|
|
2019
Q4 | $25.3M | Buy |
123,682
+17,878
| +17% | +$3.65M | 0.01% | 1435 |
|
|
2019
Q3 | $8.5M | Sell |
105,804
-7,735
| -7% | -$621K | ﹤0.01% | 2011 |
|
|
2019
Q2 | $10.7M | Buy |
113,539
+9,755
| +9% | +$920K | ﹤0.01% | 1929 |
|
|
2019
Q1 | $8.87M | Buy |
103,784
+13,782
| +15% | +$1.18M | ﹤0.01% | 2030 |
|
|
2018
Q4 | $5.05M | Sell |
90,002
-4,879
| -5% | -$274K | ﹤0.01% | 2283 |
|
|
2018
Q3 | $7.76M | Buy |
94,881
+29,294
| +45% | +$2.4M | ﹤0.01% | 2175 |
|
|
2018
Q2 | $2.29M | Buy |
65,587
+16,473
| +34% | +$576K | ﹤0.01% | 2779 |
|
|
2018
Q1 | $1.01M | Buy |
49,114
+1,950
| +4% | +$40K | ﹤0.01% | 3212 |
|
|
2017
Q4 | $1.34M | Buy |
47,164
+2,461
| +6% | +$69.7K | ﹤0.01% | 3070 |
|
|
2017
Q3 | $1.39M | Buy |
44,703
+10,744
| +32% | +$334K | ﹤0.01% | 3027 |
|
|
2017
Q2 | $1.07M | Buy |
33,959
+11,746
| +53% | +$371K | ﹤0.01% | 3207 |
|
|
2017
Q1 | $503K | Buy |
22,213
+3,407
| +18% | +$77.1K | ﹤0.01% | 3553 |
|
|
2016
Q4 | $411K | Buy |
18,806
+3,236
| +21% | +$70.7K | ﹤0.01% | 3670 |
|
|
2016
Q3 | $410K | Buy |
15,570
+4,599
| +42% | +$121K | ﹤0.01% | 3627 |
|
|
2016
Q2 | $217K | Buy |
+10,971
| New | +$217K | ﹤0.01% | 3871 |
|